medigraphic.com
Instituto Nacional de Salud Pública

2007, Number 5

<< Back Next >>

salud publica mex 2007; 49 (5)

Incidence and transmission patterns of rubella in Mexico.

Díaz-Ortega JL, Meneses-Reyes CD, Palacios-Martínez M

Language: Spanish
References: 39
Page: 337-344
PDF size: 271.81 Kb.


ABSTRACT

Objective. To describe changes in the transmission patterns of rubella in Mexico. Material and Methods. An analysis of rubella incidence during 1990-2005 was performed to estimate the morbidity trend through a simple linear regression model. Endemic mapping was carried out by logarithmic transformation of the geometric mean of monthly incidence rates and 95% CI to estimate high and low endemic ranges. Results. A stable trend was observed in morbidity during 1990-1998 ,descending during 1999-2005 (r=-0.88, r2=0.77), with a 97.1% cumulative decrease. Attenuation during seasonal variation, temporary interruption of transmission in 13 states and increase in the proportion of cases in 15-44 year-olds as well as in children less than one year of age, have been observed respectively after starting vaccination of children less than seven years of age and the implementation of combined strategy (children and adults) for rubella immunization, with incidence decrease in both groups. Conclusions. Reinforcement of surveillance and routine-supplemental immunization activities would favor the interruption of endemic rubella and contribute to the continent-wide elimination proposal for 2010.


REFERENCES

  1. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982;2:781-784.

  2. Cutts FT, Robertson SE, Díaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS. Bull World Health Organ 1997;75:55-68.

  3. Robertson SE, Featherstone DA, Gacic-Dobo M, Hersh BS. Rubella and congenital rubella syndrome: global update. Pan Am J Public Health 2003;14:306-315.

  4. Cutts F, Vynnycky E. Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol 1999;28:1176-1184.

  5. Orenstein WA, Bart KJ, Hinman AR, Preblud SR, Greaves WL, Doster SW, Stetler HC, Sirotkin B. The opportunity and obligation to eliminate rubella from the United States. JAMA 1984;251:1988-1994.

  6. Fine PM. Herd immunity: history, theory, practice. Epidemiol Rev 1993;15:265-302.

  7. Anderson RM, May RM. Infectious diseases of humans. Oxford: Oxford Science Publications; 1991:13-23.

  8. CDC. Achievements in public health: elimination of rubella and congenital rubella syndrome. United States, 1969-2004. MMWR 2005;54:279-282.

  9. Dirección General de Epidemiología. Anuarios de morbilidad 1984- 2006. Disponible en: http://www.dgepi.salud.gob.mx.

  10. Dirección General de Epidemiología. Manual para la vigilancia epidemiológica de sarampión. México: Secretaría de Salud; 1993.

  11. Kim AJ, Roses PM. Elimination of rubella and congenital rubella sindrome in the Americas: another opportunity to address inequalities in health. Pan Am J Public Health 2004;15:145-146.

  12. Eliminación de la rubeola y del síndrome de rubeola congénita. Guía práctica. Publicación científica y técnica 606. Washington: Organización Panamericana de la Salud; 2005.

  13. Dirección General de Epidemiología. Procedimientos para la vigilancia epidemiológica de sarampión. Disponible en: http://www.salud.gob.mx.

  14. Norma Oficial Mexicana NOM-036-SSA2-2002, para prevención y control de enfermedades, aplicación de vacunas, toxoides, sueros, antitoxinas e inmunoglobulinas en el humano. Diario Oficial de la Federación. México, DF, 21 de febrero de 2001.

  15. Consejo Nacional de Vacunación. Manual de procedimientos técnicos de vacunación. Actualización 2003. México: Secretaría de Salud; 2003.

  16. Disponible en: http://www.conava.gob.mx.

  17. Aguirre Jaime A. Introducción al tratamiento de series temporales. Aplicación a las ciencias de la salud. Madrid: Editorial Díaz de Santos; 1994:25-172.

  18. Kleinbaum DG, Kupper DG, Morgenstern H. Epidemiologic research. Principles and quantitative methods. New York: Van Nostrand Reinhold Co.; 1982.

  19. Bortman M. Elaboración de corredores o canales endémicos mediante planillas de cálculo. Rev Panam Salud Publica 1999;5:1-8.

  20. Helfenstein U. Box-Jenkins modelling of some viral infectious diseases. Stat Med 1986;5:37-47.

  21. Thacker SB, Stroup DF. Public health surveillance. En: Browson RC, Petitti DB, editors. Applied epidemiology. Oxford: Oxford University Press; 1998:105-135.

  22. Fine PEM. The contribution of modeling to vaccination policy. En: Cutts FT, Smith PG, eds. Vaccination and world health. New York: John Willey & Sons; 1994:177-194.

  23. Canals LM, Labra SF. Análisis no-lineal de la dinámica de enfermedades infecciosas en Chile. Rev Med Chil 1999;127:1086-1092.

  24. Anderson RM, May RM. Directly transmitted infectious diseases: control by vaccination. Science 1982;215:1053-1060.

  25. Susser M. The logic in ecological: I. The logic of analysis. Am J Public Health 1994;84:825-829.

  26. Lehane DE, Newberg NR, Beam Jr WE. Evaluation of rubella herd immunity during an epidemic. JAMA 1970;213:2236-2239.

  27. José MV, Olvera J. La seroepidemiología de la rubeola en México: Datos y teoría. Salud Publica Mex 1992;34:328-334.

  28. Knox EG. Theoretical aspects of rubella vaccination strategies. Rev Infect Dis 1985;7(suppl 1):S194-S197.

  29. Gutiérrez G, Muñoz O, Tapia Conyer R, Bustamante Calvillo ME, Álvarez y Muñoz MT, Guiscafré Gallardo H, Magos C, Sepúlveda J. Seroepidemiología de la rubeola en mujeres mexicanas. Encuesta Nacional Probabilística. Salud Publica Mex 1990;32:623-631.

  30. José MV. El periodo interepidémico en poblaciones estacionarias y no estacionarias. Ciencia 1996;47:380-390.

  31. Edmunds WJ, van de Heijden OG, Eerola M, Gay NJ- Modelling rubella in Europe. Epidemiol Infect 2000;125:617-634.

  32. Reef SE, Frey TK, Theall K, Abernathy E, Burnett CL, Icenogle J, McCauley MM, Wharton M. The changing epidemiology of rubella in the 1990s. On the verge of elimination and new challenges for control and prevention. JAMA 2002;287:464-472.

  33. Massad E, Nascimento Burattini M, Azevedo Neto RS, Yang HM, Cotinho FAB, Zanetta DMT. A model-based design of a vaccination strategy against rubella in a non-immunized community of Sao Paulo State, Brazil. Epidemiol Infect 1994;112:579-594.

  34. Massad E, Azevedo-Neto RS, Burattini MN, Zanetta DMT, Coutinho FAB, Yang HM et al. Assessing the efficacy of a mixed vaccination strategy against rubella in Sao Paulo, Brazil. Int J Epidemiol 1995;24:842-850.

  35. José MV, Olvera J, Serrano O. Epidemiología de la rubeola en México. Salud Publica Mex 1992;34:318-237.

  36. Irons B, Lewis MJ, Dahl-Regis M, Castillo-Solórzano C, De Quadros CA. Strategies to eradicate rubella in English-Speaking Caribbean. Am J Public Health 2000;90:1545-1549.

  37. Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, De Quadros CA. New horizons in the control of rubella and prevention of congenital rubella síndrome in the Americas. J Infect Dis 2003;187(supppl 1):S146-S152.

  38. Castillo-Solórzano C, Andrus JK. Rubella elimination and improving health care for women. Emerging Infect Dis 2004;10:2017-2021.

  39. Irons B, Carrasco P, Morris-Glasgow V, Castillo-Solórzano C, De Quadros CA. Integrating measles and rubella surveillance: The experience in the Caribbean. J Infect Dis 2003;187(suppl 1):S153-S157.




2020     |     www.medigraphic.com